$CNXC

Concentrix Posts Mixed Q3 Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday’s

Concentrix Corp (NASDAQ:CNXC) shares fell 10.6% premarket after reporting mixed Q3 results, missing sales estimates and issuing weak Q4 guidance. The company also narrowed its FY26 adjusted EPS guidance and cut FY26 sales guidance below estimates. Earnings of $2.92 per share beat estimates, while sales of $2.454 billion missed expectations.

Original reporting
Published Sep 30, 2026, 12:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 12:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CNXC
Bearish
high confidence
Mentioned
$CNXC
Relevance
8/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$CNXCBearishHigh
01

Why it matters

The earnings miss and guidance cut triggered a 10.6% pre‑market decline, indicating immediate market reaction and potential continued volatility.

02

Market read

The report provides fresh, material information that directly impacts CNXC's stock price and may influence sector sentiment.

03

What to watch

Potential cost‑saving initiatives or new contract wins not disclosed yet may mitigate the guidance shortfall.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Concentrix, a provider of customer experience services, released its Q3 2026 earnings, beating EPS expectations but missing revenue forecasts and lowering its FY guidance.

Company-level read

Ticker impact

$CNXCBearishHigh confidence
Context

Concentrix reported mixed Q3 results and cut FY26 guidance, causing a 10.6% pre‑market drop.

Expected impact

likely further decline as investors price in weaker outlook

Evidence & confidence

Earnings beat on EPS but miss on revenue and lowered guidance typically trigger sell‑offs, especially with a double‑digit pre‑market move.

Market effects

May weigh on the business‑process outsourcing sector as peers could face similar guidance scrutiny.

U.S. tech‑service stocks could see modest pressure in early trading.

Limited; primarily affects U.S. listed BPO firms.

Counterpoint

If the EPS beat signals operational strength, the stock could rebound on short‑term oversell.

Key entities

  • Concentrix Corporation

    Subject of the earnings release and guidance cut.

Related articles

$CNXCHighAI 8/10

Concentrix earnings analysis: questions answered and next catalysts

Concentrix Corp (CNXC) reported Q3 earnings with a $0.21 EPS beat ($2.92) but a $30M revenue miss ($2.45B vs. $2.48B est). Shares initially dropped 9.77% before recovering 3.12%. Management highlighted AI-driven revenue growth (50% of total) and cash flow strength ($218M), but revenue declines due to specific client exits and offshoring. The dividend was raised to $0.37/share. Growth is expected to return in 2028, with key catalysts including Q4 earnings and debt paydown milestones.

$CNXCMedAI 8/10

Why Concentrix Stock Ended Up Moving Higher Today

Concentrix (CNXC) reported fiscal Q3 revenue below estimates due to client shifts, but earnings beat expectations. CEO Christopher Caldwell attributed the shortfall to client preferences, not customer loss. The stock initially dropped but recovered, up 3% by midday. Analysts' average price target is $33.50, over 30% above current levels.

$LQDAMed

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.

$CNXCLow

Why Concentrix (CNXC) Stock Is Up Today

Concentrix (CNXC) stock rose 4% after reporting a Q3 net loss of $988.1M, driven by a $1.5B goodwill impairment charge. Revenue fell 1.2% YoY to $2.45B, missing estimates. Adjusted EPS was $2.92. The company cited AI deployments and client decisions for the decline. Shares later cooled to $25.73, up 1%.

$BAMed

Stocks making the biggest moves premarket: Robinhood, Boeing, Moderna & more

Boeing shares rose 2% after securing a $20B defense contract. Robinhood gained 2% with new AI features and 24/7 trading plans. Concentrix dropped 9.5% on weak earnings and guidance. Moderna fell 6% after a Citi downgrade. FormFactor rose 1% on a Deutsche Bank buy rating. Cal-Maine Foods declined 6.5% on larger-than-expected losses.

$CNXCHighAI 8/10

Concentrix (CNXC) Q3 2026 Earnings Call Transcript

Concentrix (CNXC) reported Q3 2026 revenue of $2.45B, down 1.2%, with non-GAAP EPS at $2.92, up $0.14 YoY. Non-GAAP operating income exceeded guidance, but GAAP net loss was $988.1M due to a $1.05B goodwill impairment charge. Q4 revenue guidance is $2.41B-$2.46B, with FY 2026 revenue expected at $9.827B-$9.877B. Management highlighted AI-driven growth and debt reduction plans.